Drug Shortage Report for SANDOZ OLMESARTAN
| Report ID | 16750 |
| Drug Identification Number | 02443422 |
| Brand name | SANDOZ OLMESARTAN |
| Common or Proper name | OLMESARTAN |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | OLMESARTAN MEDOXOMIL |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30 |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2017-07-14 |
| Estimated end date | 2017-08-14 |
| Actual end date | 2017-09-04 |
| Shortage status | Resolved |
| Updated date | 2017-09-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2017-09-06 | French | Compare |
| v3 | 2017-09-06 | English | Compare |
| v2 | 2017-07-24 | French | Compare |
| v1 | 2017-07-24 | English | Compare |
Showing 1 to 4 of 4